Stryker vs. Johnson & Johnson vs. Zimmer Biomet: How they compare in Q4

Spinal Tech

Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth quarter financial results, and data on their orthopedic sales.

Here is how their fourth-quarter finances compare:

Stryker 

Total sales: $5.2 billion (+10.7 percent) 

Orthopedics and spine: $2.1 billion (+4.3 percent) 

Hips: $375 million (+6.7 percent)

Knees: $552 million (+5.4 percent)

Johnson & Johnson

Total sales: $23.7 billion (-4.4 percent)

Spine, sports and other: $699 million (-1.3 percent) 

Orthopedic: $2.1 billion (-0.4 percent) 

Hips: $385 million (+1.7 percent)

Knees: $354 million (+3.4 percent)

Zimmer Biomet

Total sales: $1.8 billion (+2.7 percent)

Hips: $488.7 million (+1.7 percent) 

Knees: $753.6 million (+4.7 percent)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $424.2 million (+3.3 percent)

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers